Allena Pharmaceuticals, Inc. Long Term Assets (Tax, Deferred)

Long Term Assets (Tax, Deferred) of ALNA for past 10 years: annual, quarterly and twelve month trailing (TTM) including Long Term Assets (Tax, Deferred) growth rates and interactive chart.


Highlights and Quick Summary

Visit stockrow.com/ALNA for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Long Term Assets (Tax, Deferred) of Allena Pharmaceuticals, Inc.

Most recent Long Term Assets (Tax, Deferred)of ALNA including historical data for past 10 years.

Interactive Chart of Long Term Assets (Tax, Deferred) of Allena Pharmaceuticals, Inc.


Business Profile of Allena Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology
Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts.